nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Betaxolol—glaucoma	0.0261	0.646	CbGbCtD
Zolmitriptan—CYP1A2—Clonidine—glaucoma	0.0143	0.354	CbGbCtD
Zolmitriptan—Melatonin—CYP1B1—glaucoma	0.00255	1	CrCbGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000564	0.00725	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00056	0.0072	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000553	0.00711	CbGpPWpGaD
Zolmitriptan—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.00051	0.00656	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000498	0.0064	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—OPN4—glaucoma	0.000484	0.00622	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00048	0.00617	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000474	0.00609	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—OPN4—glaucoma	0.000473	0.00609	CbGpPWpGaD
Zolmitriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000449	0.00577	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—SLC6A13—glaucoma	0.000446	0.00573	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—PTGFR—glaucoma	0.000435	0.0056	CbGpPWpGaD
Zolmitriptan—Dyspnoea—Pilocarpine—glaucoma	0.000435	0.000494	CcSEcCtD
Zolmitriptan—Pain—Brinzolamide—glaucoma	0.000434	0.000493	CcSEcCtD
Zolmitriptan—Somnolence—Pilocarpine—glaucoma	0.000433	0.000493	CcSEcCtD
Zolmitriptan—Angiopathy—Betaxolol—glaucoma	0.000433	0.000492	CcSEcCtD
Zolmitriptan—Pruritus—Bimatoprost—glaucoma	0.000432	0.000491	CcSEcCtD
Zolmitriptan—Immune system disorder—Betaxolol—glaucoma	0.000431	0.00049	CcSEcCtD
Zolmitriptan—Diarrhoea—Apraclonidine—glaucoma	0.000431	0.00049	CcSEcCtD
Zolmitriptan—Malaise—Clonidine—glaucoma	0.00043	0.000489	CcSEcCtD
Zolmitriptan—Dyspepsia—Pilocarpine—glaucoma	0.000429	0.000488	CcSEcCtD
Zolmitriptan—Chills—Betaxolol—glaucoma	0.000428	0.000487	CcSEcCtD
Zolmitriptan—Syncope—Clonidine—glaucoma	0.000428	0.000487	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—OPN4—glaucoma	0.000427	0.00549	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000426	0.00548	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—PTGFR—glaucoma	0.000426	0.00548	CbGpPWpGaD
Zolmitriptan—Arrhythmia—Betaxolol—glaucoma	0.000426	0.000485	CcSEcCtD
Zolmitriptan—MAOA—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000426	0.00547	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Dorzolamide—glaucoma	0.000425	0.000484	CcSEcCtD
Zolmitriptan—Decreased appetite—Pilocarpine—glaucoma	0.000424	0.000482	CcSEcCtD
Zolmitriptan—Feeling abnormal—Travoprost—glaucoma	0.000423	0.000481	CcSEcCtD
Zolmitriptan—Conjunctivitis—Timolol—glaucoma	0.000422	0.00048	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000422	0.00048	CcSEcCtD
Zolmitriptan—Palpitations—Clonidine—glaucoma	0.000422	0.000479	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000421	0.000479	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Travoprost—glaucoma	0.00042	0.000478	CcSEcCtD
Zolmitriptan—Loss of consciousness—Clonidine—glaucoma	0.000419	0.000477	CcSEcCtD
Zolmitriptan—Feeling abnormal—Brinzolamide—glaucoma	0.000418	0.000475	CcSEcCtD
Zolmitriptan—MAOA—Biological oxidations—GSTT1—glaucoma	0.000418	0.00537	CbGpPWpGaD
Zolmitriptan—Constipation—Pilocarpine—glaucoma	0.000417	0.000474	CcSEcCtD
Zolmitriptan—Pain—Pilocarpine—glaucoma	0.000417	0.000474	CcSEcCtD
Zolmitriptan—Cough—Clonidine—glaucoma	0.000416	0.000473	CcSEcCtD
Zolmitriptan—Sweating—Timolol—glaucoma	0.000416	0.000473	CcSEcCtD
Zolmitriptan—Dizziness—Apraclonidine—glaucoma	0.000416	0.000473	CcSEcCtD
Zolmitriptan—Erythema—Betaxolol—glaucoma	0.000415	0.000472	CcSEcCtD
Zolmitriptan—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000413	0.0053	CbGpPWpGaD
Zolmitriptan—Urticaria—Dorzolamide—glaucoma	0.00041	0.000466	CcSEcCtD
Zolmitriptan—Epistaxis—Timolol—glaucoma	0.000409	0.000466	CcSEcCtD
Zolmitriptan—Body temperature increased—Dorzolamide—glaucoma	0.000408	0.000464	CcSEcCtD
Zolmitriptan—Abdominal pain—Dorzolamide—glaucoma	0.000408	0.000464	CcSEcCtD
Zolmitriptan—Tension—Betaxolol—glaucoma	0.000408	0.000463	CcSEcCtD
Zolmitriptan—Sinusitis—Timolol—glaucoma	0.000407	0.000463	CcSEcCtD
Zolmitriptan—Dysgeusia—Betaxolol—glaucoma	0.000407	0.000463	CcSEcCtD
Zolmitriptan—Arthralgia—Clonidine—glaucoma	0.000406	0.000462	CcSEcCtD
Zolmitriptan—Chest pain—Clonidine—glaucoma	0.000406	0.000462	CcSEcCtD
Zolmitriptan—Abdominal pain—Travoprost—glaucoma	0.000406	0.000462	CcSEcCtD
Zolmitriptan—Anxiety—Clonidine—glaucoma	0.000405	0.00046	CcSEcCtD
Zolmitriptan—Asthenia—Acetazolamide—glaucoma	0.000404	0.000459	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000404	0.00519	CbGpPWpGaD
Zolmitriptan—Dizziness—Bimatoprost—glaucoma	0.000403	0.000459	CcSEcCtD
Zolmitriptan—Nervousness—Betaxolol—glaucoma	0.000403	0.000459	CcSEcCtD
Zolmitriptan—Urticaria—Brinzolamide—glaucoma	0.000403	0.000458	CcSEcCtD
Zolmitriptan—Feeling abnormal—Pilocarpine—glaucoma	0.000402	0.000457	CcSEcCtD
Zolmitriptan—Discomfort—Clonidine—glaucoma	0.000401	0.000456	CcSEcCtD
Zolmitriptan—Vomiting—Apraclonidine—glaucoma	0.0004	0.000455	CcSEcCtD
Zolmitriptan—Muscle spasms—Betaxolol—glaucoma	0.000399	0.000454	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000399	0.000453	CcSEcCtD
Zolmitriptan—Hypersensitivity—Brimonidine—glaucoma	0.000398	0.000453	CcSEcCtD
Zolmitriptan—Dry mouth—Clonidine—glaucoma	0.000397	0.000452	CcSEcCtD
Zolmitriptan—Bradycardia—Timolol—glaucoma	0.000397	0.000451	CcSEcCtD
Zolmitriptan—Dermatitis—Apraclonidine—glaucoma	0.000396	0.000451	CcSEcCtD
Zolmitriptan—Headache—Apraclonidine—glaucoma	0.000394	0.000448	CcSEcCtD
Zolmitriptan—Confusional state—Clonidine—glaucoma	0.000393	0.000446	CcSEcCtD
Zolmitriptan—Rhinitis—Timolol—glaucoma	0.000391	0.000444	CcSEcCtD
Zolmitriptan—Oedema—Clonidine—glaucoma	0.000389	0.000443	CcSEcCtD
Zolmitriptan—Tremor—Betaxolol—glaucoma	0.000389	0.000443	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—OPN4—glaucoma	0.000388	0.00499	CbGpPWpGaD
Zolmitriptan—Hallucination—Timolol—glaucoma	0.000388	0.000441	CcSEcCtD
Zolmitriptan—Asthenia—Brimonidine—glaucoma	0.000388	0.000441	CcSEcCtD
Zolmitriptan—Infection—Clonidine—glaucoma	0.000387	0.00044	CcSEcCtD
Zolmitriptan—Abdominal pain—Pilocarpine—glaucoma	0.000385	0.000438	CcSEcCtD
Zolmitriptan—Body temperature increased—Pilocarpine—glaucoma	0.000385	0.000438	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Betaxolol—glaucoma	0.000385	0.000438	CcSEcCtD
Zolmitriptan—Diarrhoea—Acetazolamide—glaucoma	0.000385	0.000438	CcSEcCtD
Zolmitriptan—HTR1F—GPCR downstream signaling—PTGFR—glaucoma	0.000385	0.00495	CbGpPWpGaD
Zolmitriptan—Rash—Bimatoprost—glaucoma	0.000385	0.000437	CcSEcCtD
Zolmitriptan—Dermatitis—Bimatoprost—glaucoma	0.000384	0.000437	CcSEcCtD
Zolmitriptan—Oedema peripheral—Timolol—glaucoma	0.000384	0.000437	CcSEcCtD
Zolmitriptan—Shock—Clonidine—glaucoma	0.000383	0.000436	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Timolol—glaucoma	0.000383	0.000436	CcSEcCtD
Zolmitriptan—Pruritus—Brimonidine—glaucoma	0.000382	0.000435	CcSEcCtD
Zolmitriptan—Headache—Bimatoprost—glaucoma	0.000382	0.000435	CcSEcCtD
Zolmitriptan—Nervous system disorder—Clonidine—glaucoma	0.000382	0.000434	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Clonidine—glaucoma	0.000381	0.000434	CcSEcCtD
Zolmitriptan—Hypersensitivity—Dorzolamide—glaucoma	0.00038	0.000432	CcSEcCtD
Zolmitriptan—Tachycardia—Clonidine—glaucoma	0.00038	0.000432	CcSEcCtD
Zolmitriptan—Hypersensitivity—Travoprost—glaucoma	0.000378	0.00043	CcSEcCtD
Zolmitriptan—Skin disorder—Clonidine—glaucoma	0.000378	0.00043	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Clonidine—glaucoma	0.000376	0.000428	CcSEcCtD
Zolmitriptan—Malaise—Betaxolol—glaucoma	0.000375	0.000426	CcSEcCtD
Zolmitriptan—Nausea—Apraclonidine—glaucoma	0.000374	0.000425	CcSEcCtD
Zolmitriptan—Hypersensitivity—Brinzolamide—glaucoma	0.000374	0.000425	CcSEcCtD
Zolmitriptan—Vertigo—Betaxolol—glaucoma	0.000373	0.000424	CcSEcCtD
Zolmitriptan—Syncope—Betaxolol—glaucoma	0.000372	0.000424	CcSEcCtD
Zolmitriptan—Dizziness—Acetazolamide—glaucoma	0.000372	0.000423	CcSEcCtD
Zolmitriptan—Anorexia—Clonidine—glaucoma	0.000371	0.000422	CcSEcCtD
Zolmitriptan—Asthenia—Dorzolamide—glaucoma	0.00037	0.000421	CcSEcCtD
Zolmitriptan—Asthenia—Travoprost—glaucoma	0.000369	0.000419	CcSEcCtD
Zolmitriptan—Palpitations—Betaxolol—glaucoma	0.000367	0.000417	CcSEcCtD
Zolmitriptan—Pruritus—Dorzolamide—glaucoma	0.000365	0.000415	CcSEcCtD
Zolmitriptan—Loss of consciousness—Betaxolol—glaucoma	0.000365	0.000415	CcSEcCtD
Zolmitriptan—Asthenia—Brinzolamide—glaucoma	0.000364	0.000414	CcSEcCtD
Zolmitriptan—Pruritus—Travoprost—glaucoma	0.000363	0.000413	CcSEcCtD
Zolmitriptan—Tinnitus—Timolol—glaucoma	0.000363	0.000413	CcSEcCtD
Zolmitriptan—Cough—Betaxolol—glaucoma	0.000362	0.000412	CcSEcCtD
Zolmitriptan—Nausea—Bimatoprost—glaucoma	0.000362	0.000412	CcSEcCtD
Zolmitriptan—Cardiac disorder—Timolol—glaucoma	0.000362	0.000411	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—OPN4—glaucoma	0.000361	0.00464	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Pilocarpine—glaucoma	0.000359	0.000408	CcSEcCtD
Zolmitriptan—Pruritus—Brinzolamide—glaucoma	0.000359	0.000408	CcSEcCtD
Zolmitriptan—Vomiting—Acetazolamide—glaucoma	0.000358	0.000407	CcSEcCtD
Zolmitriptan—Dizziness—Brimonidine—glaucoma	0.000357	0.000406	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000355	0.000403	CcSEcCtD
Zolmitriptan—Angiopathy—Timolol—glaucoma	0.000354	0.000402	CcSEcCtD
Zolmitriptan—Chest pain—Betaxolol—glaucoma	0.000354	0.000402	CcSEcCtD
Zolmitriptan—Arthralgia—Betaxolol—glaucoma	0.000354	0.000402	CcSEcCtD
Zolmitriptan—Myalgia—Betaxolol—glaucoma	0.000354	0.000402	CcSEcCtD
Zolmitriptan—Diarrhoea—Dorzolamide—glaucoma	0.000353	0.000401	CcSEcCtD
Zolmitriptan—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000353	0.00453	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000353	0.00453	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000353	0.00453	CbGpPWpGaD
Zolmitriptan—Headache—Acetazolamide—glaucoma	0.000353	0.000401	CcSEcCtD
Zolmitriptan—Anxiety—Betaxolol—glaucoma	0.000352	0.000401	CcSEcCtD
Zolmitriptan—Insomnia—Clonidine—glaucoma	0.000352	0.0004	CcSEcCtD
Zolmitriptan—Immune system disorder—Timolol—glaucoma	0.000352	0.0004	CcSEcCtD
Zolmitriptan—Diarrhoea—Travoprost—glaucoma	0.000351	0.0004	CcSEcCtD
Zolmitriptan—Asthenia—Pilocarpine—glaucoma	0.00035	0.000398	CcSEcCtD
Zolmitriptan—Paraesthesia—Clonidine—glaucoma	0.00035	0.000398	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—PTGFR—glaucoma	0.000349	0.00449	CbGpPWpGaD
Zolmitriptan—Discomfort—Betaxolol—glaucoma	0.000349	0.000397	CcSEcCtD
Zolmitriptan—Arrhythmia—Timolol—glaucoma	0.000348	0.000396	CcSEcCtD
Zolmitriptan—Dyspnoea—Clonidine—glaucoma	0.000347	0.000395	CcSEcCtD
Zolmitriptan—Diarrhoea—Brinzolamide—glaucoma	0.000347	0.000395	CcSEcCtD
Zolmitriptan—Somnolence—Clonidine—glaucoma	0.000346	0.000394	CcSEcCtD
Zolmitriptan—Dry mouth—Betaxolol—glaucoma	0.000346	0.000393	CcSEcCtD
Zolmitriptan—Pruritus—Pilocarpine—glaucoma	0.000345	0.000392	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000343	0.00441	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—SMO—glaucoma	0.000343	0.00441	CbGpPWpGaD
Zolmitriptan—Confusional state—Betaxolol—glaucoma	0.000342	0.000389	CcSEcCtD
Zolmitriptan—Dizziness—Dorzolamide—glaucoma	0.000341	0.000388	CcSEcCtD
Zolmitriptan—Rash—Brimonidine—glaucoma	0.000341	0.000387	CcSEcCtD
Zolmitriptan—Dermatitis—Brimonidine—glaucoma	0.00034	0.000387	CcSEcCtD
Zolmitriptan—Dizziness—Travoprost—glaucoma	0.00034	0.000386	CcSEcCtD
Zolmitriptan—Erythema—Timolol—glaucoma	0.000339	0.000386	CcSEcCtD
Zolmitriptan—Oedema—Betaxolol—glaucoma	0.000339	0.000385	CcSEcCtD
Zolmitriptan—Headache—Brimonidine—glaucoma	0.000338	0.000385	CcSEcCtD
Zolmitriptan—Decreased appetite—Clonidine—glaucoma	0.000338	0.000385	CcSEcCtD
Zolmitriptan—Infection—Betaxolol—glaucoma	0.000337	0.000383	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000336	0.000382	CcSEcCtD
Zolmitriptan—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000335	0.00431	CbGpPWpGaD
Zolmitriptan—Dizziness—Brinzolamide—glaucoma	0.000335	0.000381	CcSEcCtD
Zolmitriptan—Nausea—Acetazolamide—glaucoma	0.000334	0.00038	CcSEcCtD
Zolmitriptan—Diarrhoea—Pilocarpine—glaucoma	0.000334	0.000379	CcSEcCtD
Zolmitriptan—Shock—Betaxolol—glaucoma	0.000333	0.000379	CcSEcCtD
Zolmitriptan—Tension—Timolol—glaucoma	0.000333	0.000379	CcSEcCtD
Zolmitriptan—Pain—Clonidine—glaucoma	0.000333	0.000379	CcSEcCtD
Zolmitriptan—Constipation—Clonidine—glaucoma	0.000333	0.000379	CcSEcCtD
Zolmitriptan—MAOA—Biological oxidations—CYP1B1—glaucoma	0.000333	0.00428	CbGpPWpGaD
Zolmitriptan—Nervous system disorder—Betaxolol—glaucoma	0.000332	0.000378	CcSEcCtD
Zolmitriptan—Dysgeusia—Timolol—glaucoma	0.000332	0.000378	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Betaxolol—glaucoma	0.000332	0.000377	CcSEcCtD
Zolmitriptan—Tachycardia—Betaxolol—glaucoma	0.000331	0.000376	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—LRP12—glaucoma	0.000331	0.00425	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00033	0.00424	CbGpPWpGaD
Zolmitriptan—Nervousness—Timolol—glaucoma	0.00033	0.000375	CcSEcCtD
Zolmitriptan—Skin disorder—Betaxolol—glaucoma	0.000329	0.000374	CcSEcCtD
Zolmitriptan—Vomiting—Dorzolamide—glaucoma	0.000328	0.000373	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Betaxolol—glaucoma	0.000328	0.000373	CcSEcCtD
Zolmitriptan—HTR1F—G alpha (i) signalling events—C3—glaucoma	0.000327	0.0042	CbGpPWpGaD
Zolmitriptan—MAOA—Neuronal System—SLC6A1—glaucoma	0.000326	0.00419	CbGpPWpGaD
Zolmitriptan—Rash—Dorzolamide—glaucoma	0.000325	0.00037	CcSEcCtD
Zolmitriptan—Dermatitis—Dorzolamide—glaucoma	0.000325	0.00037	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—PTGFR—glaucoma	0.000325	0.00417	CbGpPWpGaD
Zolmitriptan—Rash—Travoprost—glaucoma	0.000324	0.000368	CcSEcCtD
Zolmitriptan—Dermatitis—Travoprost—glaucoma	0.000324	0.000368	CcSEcCtD
Zolmitriptan—Headache—Dorzolamide—glaucoma	0.000323	0.000368	CcSEcCtD
Zolmitriptan—Anorexia—Betaxolol—glaucoma	0.000323	0.000367	CcSEcCtD
Zolmitriptan—Vomiting—Brinzolamide—glaucoma	0.000322	0.000367	CcSEcCtD
Zolmitriptan—Dizziness—Pilocarpine—glaucoma	0.000322	0.000367	CcSEcCtD
Zolmitriptan—Headache—Travoprost—glaucoma	0.000322	0.000366	CcSEcCtD
Zolmitriptan—Nausea—Brimonidine—glaucoma	0.000321	0.000365	CcSEcCtD
Zolmitriptan—Feeling abnormal—Clonidine—glaucoma	0.000321	0.000365	CcSEcCtD
Zolmitriptan—Rash—Brinzolamide—glaucoma	0.00032	0.000364	CcSEcCtD
Zolmitriptan—Dermatitis—Brinzolamide—glaucoma	0.00032	0.000363	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Clonidine—glaucoma	0.000318	0.000362	CcSEcCtD
Zolmitriptan—Headache—Brinzolamide—glaucoma	0.000318	0.000361	CcSEcCtD
Zolmitriptan—Angioedema—Timolol—glaucoma	0.00031	0.000353	CcSEcCtD
Zolmitriptan—Vomiting—Pilocarpine—glaucoma	0.00031	0.000353	CcSEcCtD
Zolmitriptan—Urticaria—Clonidine—glaucoma	0.000309	0.000352	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000309	0.000351	CcSEcCtD
Zolmitriptan—Abdominal pain—Clonidine—glaucoma	0.000308	0.00035	CcSEcCtD
Zolmitriptan—Body temperature increased—Clonidine—glaucoma	0.000308	0.00035	CcSEcCtD
Zolmitriptan—Rash—Pilocarpine—glaucoma	0.000307	0.00035	CcSEcCtD
Zolmitriptan—Dermatitis—Pilocarpine—glaucoma	0.000307	0.000349	CcSEcCtD
Zolmitriptan—Insomnia—Betaxolol—glaucoma	0.000307	0.000349	CcSEcCtD
Zolmitriptan—Nausea—Dorzolamide—glaucoma	0.000306	0.000349	CcSEcCtD
Zolmitriptan—Headache—Pilocarpine—glaucoma	0.000305	0.000347	CcSEcCtD
Zolmitriptan—Nausea—Travoprost—glaucoma	0.000305	0.000347	CcSEcCtD
Zolmitriptan—Vertigo—Timolol—glaucoma	0.000305	0.000347	CcSEcCtD
Zolmitriptan—Paraesthesia—Betaxolol—glaucoma	0.000304	0.000346	CcSEcCtD
Zolmitriptan—Syncope—Timolol—glaucoma	0.000304	0.000346	CcSEcCtD
Zolmitriptan—Dyspnoea—Betaxolol—glaucoma	0.000302	0.000344	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000301	0.00388	CbGpPWpGaD
Zolmitriptan—Nausea—Brinzolamide—glaucoma	0.000301	0.000343	CcSEcCtD
Zolmitriptan—Palpitations—Timolol—glaucoma	0.0003	0.000341	CcSEcCtD
Zolmitriptan—Dyspepsia—Betaxolol—glaucoma	0.000298	0.000339	CcSEcCtD
Zolmitriptan—Loss of consciousness—Timolol—glaucoma	0.000298	0.000339	CcSEcCtD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000297	0.00382	CbGpPWpGaD
Zolmitriptan—Cough—Timolol—glaucoma	0.000296	0.000337	CcSEcCtD
Zolmitriptan—Decreased appetite—Betaxolol—glaucoma	0.000295	0.000335	CcSEcCtD
Zolmitriptan—Hypertension—Timolol—glaucoma	0.000293	0.000333	CcSEcCtD
Zolmitriptan—MAOA—Metabolism—CA5A—glaucoma	0.000293	0.00376	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NARFL—glaucoma	0.000293	0.00376	CbGpPWpGaD
Zolmitriptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000293	0.000333	CcSEcCtD
Zolmitriptan—Pain—Betaxolol—glaucoma	0.00029	0.00033	CcSEcCtD
Zolmitriptan—Constipation—Betaxolol—glaucoma	0.00029	0.00033	CcSEcCtD
Zolmitriptan—Nausea—Pilocarpine—glaucoma	0.00029	0.000329	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000289	0.00372	CbGpPWpGaD
Zolmitriptan—Arthralgia—Timolol—glaucoma	0.000289	0.000328	CcSEcCtD
Zolmitriptan—Chest pain—Timolol—glaucoma	0.000289	0.000328	CcSEcCtD
Zolmitriptan—Myalgia—Timolol—glaucoma	0.000289	0.000328	CcSEcCtD
Zolmitriptan—Anxiety—Timolol—glaucoma	0.000288	0.000327	CcSEcCtD
Zolmitriptan—Hypersensitivity—Clonidine—glaucoma	0.000287	0.000326	CcSEcCtD
Zolmitriptan—Discomfort—Timolol—glaucoma	0.000285	0.000325	CcSEcCtD
Zolmitriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000285	0.00367	CbGpPWpGaD
Zolmitriptan—Dry mouth—Timolol—glaucoma	0.000282	0.000321	CcSEcCtD
Zolmitriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000281	0.00362	CbGpPWpGaD
Zolmitriptan—Asthenia—Clonidine—glaucoma	0.000279	0.000318	CcSEcCtD
Zolmitriptan—Feeling abnormal—Betaxolol—glaucoma	0.000279	0.000318	CcSEcCtD
Zolmitriptan—Confusional state—Timolol—glaucoma	0.000279	0.000318	CcSEcCtD
Zolmitriptan—Oedema—Timolol—glaucoma	0.000277	0.000315	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Timolol—glaucoma	0.000277	0.000315	CcSEcCtD
Zolmitriptan—Pruritus—Clonidine—glaucoma	0.000275	0.000313	CcSEcCtD
Zolmitriptan—Infection—Timolol—glaucoma	0.000275	0.000313	CcSEcCtD
Zolmitriptan—HTR1D—GPCR downstream signaling—OPN4—glaucoma	0.000273	0.00351	CbGpPWpGaD
Zolmitriptan—Shock—Timolol—glaucoma	0.000272	0.00031	CcSEcCtD
Zolmitriptan—Nervous system disorder—Timolol—glaucoma	0.000272	0.000309	CcSEcCtD
Zolmitriptan—Urticaria—Betaxolol—glaucoma	0.000269	0.000306	CcSEcCtD
Zolmitriptan—Skin disorder—Timolol—glaucoma	0.000269	0.000306	CcSEcCtD
Zolmitriptan—Body temperature increased—Betaxolol—glaucoma	0.000268	0.000305	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Timolol—glaucoma	0.000268	0.000304	CcSEcCtD
Zolmitriptan—HTR1B—GPCR downstream signaling—OPN4—glaucoma	0.000268	0.00344	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—NGF—glaucoma	0.000268	0.00344	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Clonidine—glaucoma	0.000266	0.000303	CcSEcCtD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000266	0.00342	CbGpPWpGaD
Zolmitriptan—MAOA—Biological oxidations—GSTM1—glaucoma	0.000266	0.00342	CbGpPWpGaD
Zolmitriptan—Anorexia—Timolol—glaucoma	0.000264	0.0003	CcSEcCtD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000263	0.00339	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00026	0.00334	CbGpPWpGaD
Zolmitriptan—Dizziness—Clonidine—glaucoma	0.000257	0.000293	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000256	0.00329	CbGpPWpGaD
Zolmitriptan—Musculoskeletal discomfort—Timolol—glaucoma	0.000252	0.000287	CcSEcCtD
Zolmitriptan—Insomnia—Timolol—glaucoma	0.00025	0.000285	CcSEcCtD
Zolmitriptan—Hypersensitivity—Betaxolol—glaucoma	0.00025	0.000284	CcSEcCtD
Zolmitriptan—Paraesthesia—Timolol—glaucoma	0.000249	0.000283	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—OPN4—glaucoma	0.000248	0.00319	CbGpPWpGaD
Zolmitriptan—Vomiting—Clonidine—glaucoma	0.000248	0.000282	CcSEcCtD
Zolmitriptan—Dyspnoea—Timolol—glaucoma	0.000247	0.000281	CcSEcCtD
Zolmitriptan—Somnolence—Timolol—glaucoma	0.000246	0.00028	CcSEcCtD
Zolmitriptan—HTR1D—GPCR downstream signaling—PTGFR—glaucoma	0.000246	0.00316	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000246	0.00316	CbGpPWpGaD
Zolmitriptan—Rash—Clonidine—glaucoma	0.000245	0.000279	CcSEcCtD
Zolmitriptan—Dermatitis—Clonidine—glaucoma	0.000245	0.000279	CcSEcCtD
Zolmitriptan—Headache—Clonidine—glaucoma	0.000244	0.000277	CcSEcCtD
Zolmitriptan—Dyspepsia—Timolol—glaucoma	0.000244	0.000277	CcSEcCtD
Zolmitriptan—Asthenia—Betaxolol—glaucoma	0.000243	0.000277	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—OPN4—glaucoma	0.000243	0.00312	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PTGFR—glaucoma	0.000241	0.0031	CbGpPWpGaD
Zolmitriptan—Decreased appetite—Timolol—glaucoma	0.000241	0.000274	CcSEcCtD
Zolmitriptan—Pruritus—Betaxolol—glaucoma	0.00024	0.000273	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Timolol—glaucoma	0.000239	0.000272	CcSEcCtD
Zolmitriptan—Pain—Timolol—glaucoma	0.000237	0.000269	CcSEcCtD
Zolmitriptan—Diarrhoea—Betaxolol—glaucoma	0.000232	0.000264	CcSEcCtD
Zolmitriptan—Nausea—Clonidine—glaucoma	0.000231	0.000263	CcSEcCtD
Zolmitriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000231	0.00297	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—OPN4—glaucoma	0.000229	0.00295	CbGpPWpGaD
Zolmitriptan—Feeling abnormal—Timolol—glaucoma	0.000228	0.00026	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000227	0.00292	CbGpPWpGaD
Zolmitriptan—Gastrointestinal pain—Timolol—glaucoma	0.000226	0.000258	CcSEcCtD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000226	0.00291	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—EDN1—glaucoma	0.000226	0.00291	CbGpPWpGaD
Zolmitriptan—Dizziness—Betaxolol—glaucoma	0.000224	0.000255	CcSEcCtD
Zolmitriptan—HTR1D—Signaling by GPCR—PTGFR—glaucoma	0.000223	0.00287	CbGpPWpGaD
Zolmitriptan—Urticaria—Timolol—glaucoma	0.00022	0.00025	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—SMO—glaucoma	0.00022	0.00282	CbGpPWpGaD
Zolmitriptan—Body temperature increased—Timolol—glaucoma	0.000219	0.000249	CcSEcCtD
Zolmitriptan—Abdominal pain—Timolol—glaucoma	0.000219	0.000249	CcSEcCtD
Zolmitriptan—HTR1B—Signaling by GPCR—PTGFR—glaucoma	0.000219	0.00281	CbGpPWpGaD
Zolmitriptan—Vomiting—Betaxolol—glaucoma	0.000215	0.000245	CcSEcCtD
Zolmitriptan—HTR1B—GPCR ligand binding—SMO—glaucoma	0.000215	0.00276	CbGpPWpGaD
Zolmitriptan—Rash—Betaxolol—glaucoma	0.000214	0.000243	CcSEcCtD
Zolmitriptan—Dermatitis—Betaxolol—glaucoma	0.000214	0.000243	CcSEcCtD
Zolmitriptan—HTR1F—Signaling Pathways—HEYL—glaucoma	0.000213	0.00274	CbGpPWpGaD
Zolmitriptan—Headache—Betaxolol—glaucoma	0.000212	0.000241	CcSEcCtD
Zolmitriptan—HTR1D—Signaling Pathways—LRP12—glaucoma	0.000211	0.00272	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—C3—glaucoma	0.000209	0.00268	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LRP12—glaucoma	0.000207	0.00266	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTGFR—glaucoma	0.000206	0.00265	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—C3—glaucoma	0.000204	0.00263	CbGpPWpGaD
Zolmitriptan—Hypersensitivity—Timolol—glaucoma	0.000204	0.000232	CcSEcCtD
Zolmitriptan—HTR1A—GPCR downstream signaling—OPN4—glaucoma	0.000204	0.00262	CbGpPWpGaD
Zolmitriptan—Nausea—Betaxolol—glaucoma	0.000201	0.000229	CcSEcCtD
Zolmitriptan—Asthenia—Timolol—glaucoma	0.000199	0.000226	CcSEcCtD
Zolmitriptan—HTR1F—GPCR ligand binding—C3—glaucoma	0.000198	0.00254	CbGpPWpGaD
Zolmitriptan—Pruritus—Timolol—glaucoma	0.000196	0.000223	CcSEcCtD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00019	0.00244	CbGpPWpGaD
Zolmitriptan—Diarrhoea—Timolol—glaucoma	0.000189	0.000215	CcSEcCtD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000186	0.00239	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—OPN4—glaucoma	0.000185	0.00238	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000184	0.00236	CbGpPWpGaD
Zolmitriptan—Dizziness—Timolol—glaucoma	0.000183	0.000208	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—SMO—glaucoma	0.000176	0.00226	CbGpPWpGaD
Zolmitriptan—Vomiting—Timolol—glaucoma	0.000176	0.0002	CcSEcCtD
Zolmitriptan—Rash—Timolol—glaucoma	0.000175	0.000199	CcSEcCtD
Zolmitriptan—Dermatitis—Timolol—glaucoma	0.000174	0.000198	CcSEcCtD
Zolmitriptan—Headache—Timolol—glaucoma	0.000173	0.000197	CcSEcCtD
Zolmitriptan—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000168	0.00216	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTGFR—glaucoma	0.000167	0.00214	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000166	0.00213	CbGpPWpGaD
Zolmitriptan—Nausea—Timolol—glaucoma	0.000164	0.000187	CcSEcCtD
Zolmitriptan—HTR1A—GPCR ligand binding—SMO—glaucoma	0.000164	0.00211	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000163	0.00209	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RPTOR—glaucoma	0.000161	0.00208	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000159	0.00204	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LRP12—glaucoma	0.000158	0.00203	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NCK2—glaucoma	0.000156	0.00201	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—C3—glaucoma	0.000156	0.002	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000154	0.00198	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000151	0.00194	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000151	0.00194	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000149	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—OPN4—glaucoma	0.000147	0.00188	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—EDN1—glaucoma	0.000145	0.00186	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—OPN4—glaucoma	0.000144	0.00185	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CA1—glaucoma	0.000143	0.00184	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000142	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—EDN1—glaucoma	0.000142	0.00182	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CTSA—glaucoma	0.000138	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HEYL—glaucoma	0.000136	0.00175	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HEYL—glaucoma	0.000133	0.00172	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—HDAC9—glaucoma	0.000133	0.00171	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTGFR—glaucoma	0.000132	0.0017	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CA2—glaucoma	0.000131	0.00168	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTGFR—glaucoma	0.000129	0.00166	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—EDN1—glaucoma	0.000128	0.00164	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000128	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—C3—glaucoma	0.000126	0.00163	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000125	0.00161	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000124	0.00159	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—C3—glaucoma	0.000124	0.00159	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000123	0.00158	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000121	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—EDN1—glaucoma	0.000116	0.00149	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000115	0.00147	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—SMO—glaucoma	0.000113	0.00145	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—C3—glaucoma	0.000112	0.00144	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—SMO—glaucoma	0.00011	0.00142	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	0.00011	0.00141	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—OPN4—glaucoma	0.000109	0.00141	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000109	0.0014	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NARFL—glaucoma	0.000108	0.00139	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA5A—glaucoma	0.000108	0.00139	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—EDN1—glaucoma	0.000108	0.00139	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000107	0.00138	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000107	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SMO—glaucoma	0.000104	0.00134	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RPTOR—glaucoma	0.000103	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HEYL—glaucoma	0.000102	0.00131	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—C3—glaucoma	0.000101	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RPTOR—glaucoma	0.000101	0.0013	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NCK2—glaucoma	0.0001	0.00129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTGFR—glaucoma	9.84e-05	0.00127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—GSTM1—glaucoma	9.82e-05	0.00126	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NCK2—glaucoma	9.79e-05	0.00126	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	9.68e-05	0.00124	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NTRK2—glaucoma	9.52e-05	0.00122	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—C3—glaucoma	9.43e-05	0.00121	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	9.31e-05	0.0012	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TXN—glaucoma	9.21e-05	0.00118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HDAC9—glaucoma	8.5e-05	0.00109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—SMO—glaucoma	8.4e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HDAC9—glaucoma	8.33e-05	0.00107	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—EDN1—glaucoma	8.18e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NGFR—glaucoma	8.17e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—EDN1—glaucoma	8.01e-05	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NTRK1—glaucoma	7.76e-05	0.000998	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RPTOR—glaucoma	7.7e-05	0.00099	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NCK2—glaucoma	7.46e-05	0.000959	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EDN1—glaucoma	7.43e-05	0.000955	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EDN1—glaucoma	7.27e-05	0.000935	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN2B—glaucoma	7.15e-05	0.000919	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTT1—glaucoma	7.15e-05	0.000919	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—C3—glaucoma	7.14e-05	0.000919	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—C3—glaucoma	7e-05	0.000899	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EDN1—glaucoma	6.86e-05	0.000882	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SMO—glaucoma	6.65e-05	0.000856	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SMO—glaucoma	6.52e-05	0.000838	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—C3—glaucoma	6.49e-05	0.000834	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—C3—glaucoma	6.35e-05	0.000817	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HDAC9—glaucoma	6.34e-05	0.000816	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NGF—glaucoma	6.3e-05	0.000811	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—EDN1—glaucoma	6.1e-05	0.000784	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTRK2—glaucoma	6.09e-05	0.000783	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—C3—glaucoma	5.99e-05	0.000771	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK2—glaucoma	5.96e-05	0.000766	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1B1—glaucoma	5.69e-05	0.000732	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ABCA1—glaucoma	5.69e-05	0.000732	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—APOE—glaucoma	5.58e-05	0.000717	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EDN1—glaucoma	5.54e-05	0.000712	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CAV1—glaucoma	5.53e-05	0.000711	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—C3—glaucoma	5.33e-05	0.000685	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA1—glaucoma	5.27e-05	0.000678	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FN1—glaucoma	5.26e-05	0.000677	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGFR—glaucoma	5.22e-05	0.000671	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—BAD—glaucoma	5.2e-05	0.000668	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGFR—glaucoma	5.11e-05	0.000657	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CTSA—glaucoma	5.11e-05	0.000657	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SMO—glaucoma	4.96e-05	0.000638	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NTRK1—glaucoma	4.96e-05	0.000638	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NTRK1—glaucoma	4.86e-05	0.000625	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—C3—glaucoma	4.84e-05	0.000622	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CA2—glaucoma	4.82e-05	0.00062	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.71e-05	0.000606	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.71e-05	0.000606	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN2B—glaucoma	4.57e-05	0.000588	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GSTM1—glaucoma	4.55e-05	0.000585	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK2—glaucoma	4.54e-05	0.000584	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN2B—glaucoma	4.48e-05	0.000576	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EDN1—glaucoma	4.39e-05	0.000564	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EDN1—glaucoma	4.3e-05	0.000552	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—glaucoma	4.18e-05	0.000537	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGF—glaucoma	4.03e-05	0.000518	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—glaucoma	4.02e-05	0.000517	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGF—glaucoma	3.95e-05	0.000508	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGFR—glaucoma	3.9e-05	0.000501	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—C3—glaucoma	3.83e-05	0.000493	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—C3—glaucoma	3.75e-05	0.000483	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—glaucoma	3.74e-05	0.000481	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CAV1—glaucoma	3.71e-05	0.000477	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK1—glaucoma	3.7e-05	0.000476	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CDKN1B—glaucoma	3.62e-05	0.000466	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—glaucoma	3.57e-05	0.000459	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CAV1—glaucoma	3.54e-05	0.000455	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—glaucoma	3.49e-05	0.000449	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CAV1—glaucoma	3.46e-05	0.000445	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN2B—glaucoma	3.41e-05	0.000438	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TXN—glaucoma	3.4e-05	0.000437	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FN1—glaucoma	3.37e-05	0.000433	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—glaucoma	3.35e-05	0.000431	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BAD—glaucoma	3.33e-05	0.000427	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FN1—glaucoma	3.29e-05	0.000424	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—glaucoma	3.27e-05	0.000421	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BAD—glaucoma	3.26e-05	0.000419	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.1e-05	0.000399	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.07e-05	0.000395	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—glaucoma	3.01e-05	0.000387	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGF—glaucoma	3.01e-05	0.000387	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—C3—glaucoma	2.86e-05	0.000368	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—glaucoma	2.81e-05	0.000361	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—glaucoma	2.67e-05	0.000344	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—glaucoma	2.66e-05	0.000342	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CAV1—glaucoma	2.64e-05	0.000339	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—glaucoma	2.64e-05	0.000339	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—glaucoma	2.62e-05	0.000337	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—glaucoma	2.57e-05	0.00033	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FN1—glaucoma	2.51e-05	0.000323	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BAD—glaucoma	2.48e-05	0.000319	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN1B—glaucoma	2.32e-05	0.000298	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—glaucoma	2.28e-05	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN1B—glaucoma	2.27e-05	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—glaucoma	2.14e-05	0.000276	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.12e-05	0.000273	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—glaucoma	2.1e-05	0.00027	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1B1—glaucoma	2.1e-05	0.00027	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCA1—glaucoma	2.1e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—glaucoma	1.99e-05	0.000256	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—glaucoma	1.93e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—glaucoma	1.89e-05	0.000242	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN1B—glaucoma	1.73e-05	0.000222	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—glaucoma	1.68e-05	0.000216	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—glaucoma	1.6e-05	0.000206	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—glaucoma	1.48e-05	0.000191	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—glaucoma	1.46e-05	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—glaucoma	1.44e-05	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—glaucoma	1.42e-05	0.000183	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—glaucoma	1.38e-05	0.000178	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAV1—glaucoma	1.37e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—glaucoma	1.09e-05	0.00014	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—glaucoma	1.03e-05	0.000133	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—glaucoma	9.46e-06	0.000122	CbGpPWpGaD
